ATGAM lymphocyte immune globulin, anti-thymocyte globulin (equine) 250mg protein 50mg/mL ampoule (USA)
Section 19A approved medicine
ATGAM lymphocyte immune globulin, anti-thymocyte globulin (equine) 250mg protein 50mg/mL ampoule (USA)
Section 19A approval holder
ORSPEC Pharma Pty Ltd ABN 15 634 980 417
Phone
02 4339 4239
Approved until
Status
Current
Medicines in short supply/unavailable
ATGAM equine antithymocyte immunoglobulin 250mg/5mL injection ampoule - ARTG 12282
Indication(s)
Renal transplant patients in whom reduction of peripheral T-lymphocyte function is desirable.
Images
